Sign In

Search |

Add/Edit My Facility

UNC Preclinical Research Unit (Preclinical Modeling / Imaging)

Subscribe to this Core


450 West Drive

LCCC Room 11-141

Chapel Hill, NC 27514

United States

https://www.med.unc.edu/pru/

Google Maps Location

cite this facility

Primary Contact:

PRU Administrators

Additional Citation Identifiers

4P30CA016086-50

Facility Details

Welcome to the Preclinical Research Unit! Our mission is to develop and utilize robust preclinical and in-vivo systems for the testing of novel cancer therapeutics. The PRU provides outstanding technical services and a seamless approach in working with the IACUC, DCM, and other core facilities on campus for labs that utilize small laboratory animals in their research. We offer technical expertise with small laboratory animal models for reproducibility of research at UNC, and complete study management as well as individual services to fit your needs. PRU technicians are experienced, highly skilled, and maintain American Association for Laboratory Animal Science Technician/Technologist (AALAS) certifications.

Funding Info

NIH - 02/07/2026 - Animal Models

is_active:

Yes

budget_end:

11/30/2025

date_added:

02/07/2026

agency_code:

NIH

fiscal_year:

2026

project_num:

4P30CA016086-50

award_amount:

$379,501.00

budget_start:

12/01/2024

org_name:

UNIV OF NORTH CAROLINA CHAPEL HILL

org_state:

NC

org_country:

UNITED STATES

org_zipcode:

275995023

primary_duns:

608195277

abstract_text:

ABSTRACT: ANIMAL MODELS SHARED RESOURCE The Animal Models (AM) SR has a long and productive history providing experimental assistance to Cancer Center members. The Genetically engineered mouse models (GEMMs), Cell-line Derived Syngeneic or Xenografts (CDX) models and Patient Derived Xenografts (PDX) models are central to LCCC basic and translational research. This is an endeavor that the LCCC and UNC helped to create through the work of the late Oliver Smithies who won the Nobel Prize for his groundbreaking techniques to allow creation of gene modified mouse models. The AM SR has grown dramatically in scope and usage over the last 20 years and is now composed of services for the creation, investigation at multiple levels and imaging of animal models of cancer. These services include: innovative methods for transgenic/knockout allele production and design, generation of PDX models from primary human tumors, allele phenotyping and colony management, animal imaging and tumorigenicity studies in CDXs (both syngeneic immunocompetent and immunocompromised models), PDXs and GEMMs. The AM SR assists Cancer Center members in the planning and execution of carefully designed animal studies. The availability of this SR and its highly skilled personnel eliminates the need for Cancer Center investigators to hire similar individuals within their laboratories and ensures a high level of rigor and reproducibility for their experiments. The three arms of this SR facility; 1) GEMM production, 2) surgery on and experimental testing of syngeneic mouse, CDX and PDX mouse models, 3) translational cancer imaging, benefit from a team of three experienced Facility Directors and well-trained staff. Users of this SR benefit from significant cost reduction and decreased completion times for their studies. The AM SR requests $235,252 from the CCSG to fund this facility in fiscal year 2020; this represents approximately 6% of the total FY19 operating costs for the AM SR which was used by over 100 labs 74% of whom were LCCC members.

project_title:

Animal Models

contact_pi_name:

WEISSMAN, BERNARD E.

total_cost:

$379,501.00

Facility Policies

Services are offerred outside of

Consulting is offerred outside of University of North Carolina at Chapel Hill

Last Updated: 08/12/2026